Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Optibrium Limited, a provider of software and artificial intelligence (AI) solutions for drug discovery, announced the publication of a peer-reviewed study in Applied AI letters “Deep Imputation on Large-Scale Drug Discovery Data”.
read more
Charles River Laboratories announced that it has completed the acquisition of Vigene Biosciences, Inc. for $292.5 million. In addition to the initial purchase price, the transaction includes additional payments of up to $57.5 million, contingent on ...
read more
IONTAS Limited, a leader in the discovery and optimization of fully human antibodies, announced that F-star Therapeutics dosed the first patients in a Phase 1 clinical trial, with FS222, a CD137/PD-L1 bispecific antibody.
read more
Aragen Life Sciences announced an expansion of their discovery research agreement with Boehringer Ingelheim, with the goal of accelerating the discovery pipeline of Boehringer Ingelheim.
read more
Paratek Pharmaceuticals Inc announced that Paratek has delivered the first procurement of NUZYRA to the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR)...
read more
Lonza announced new investments in GMP laboratories and mid-scale manufacturing assets at its API manufacturing center in Nansha, China. The investments, totaling over $22 million, will allow Lonza to provide a smoother transition from small-scale to...
read more
Frontage Laboratories has entered into an agreement to acquire Quintara Discovery. The transaction is expected to close in the third quarter of 2021. Frontage Labs will finance the transaction through the Company's internal resources.
read more
CluePoints, a provider of quality management solutions for clinical trials, launched a new Post-COVID Trial Assurance Solution. The solution offers study teams the opportunity to assess the quality of their data within a defined timeline and with ...
read more
Takara Bio Inc. announced a License and Supply Agreement with BioNTech Cell & Gene Therapies GmbH ("BioNTech"), a BioNTech SE company (www.BioNTech.de), Germany, under which Takara Bio grants BioNTech a commercial license to use applicable patents ...
read more
Novasep, a supplier of services and technologies for the life sciences industry, announced a €6.1 million investment at its Mourenx facility(Pyrénées-Atlantiques – France). This investment will modernize its API manufacturing facility.
read more
Veradigm®, a healthcare data and technology company and business unit of Allscripts Healthcare Solutions, and PRA Health Sciences Inc., a global contract research organization, announced the creation of the industry’s leading electronic healthcare ...
read more
Samsung Biologics, a contract development and manufacturing organization (CMDO), celebrated the one-year mark of Live Virtual Tour (LVT), a platform to provide remote site inspections for clients and regulatory agencies. The tool was developed and ...
read more
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it has reached an agreement to acquire ...
read more
Chemomab Therapeutics,Ltd., a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, and AGC Biologics, a global Biopharmaceutical Contract Development ...
read more
Breckenridge Pharmaceutical, Inc. announced the signing of a multi-product agreement with Aggrega Pharma, LLC. under which Aggrega will develop, manufacture and supply pharmaceutical products for marketing, sale and distribution by Breckenridge.
read more